Aerovate Therapeutics, Inc. (NASDAQ:AVTE) to Issue Dividend of $2.40
I'm PortAI, I can summarize articles.
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) announced a dividend of $2.40 per share, payable on April 28th to shareholders of record as of April 25th. The ex-dividend date is April 29th. The company's stock opened at $2.68, with a market cap of $77.68 million. Aerovate reported an EPS of ($0.09) for the last quarter, surpassing estimates. Analysts project a fiscal year EPS of -2.64. Aerovate focuses on developing treatments for rare cardiopulmonary diseases, particularly AV-101 for pulmonary arterial hypertension, currently in Phase 2b/Phase 3 trials.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments